Raptor Announces CEO Succession Plan; Dr. Christopher Starr To Retire As CEO At Year-End 2014, Julie Anne Smith Named President And CEO-Designate

By: via Benzinga
Raptor Pharmaceuticals (Nasdaq: RPTP) today announced that Julie Anne Smith, Executive Vice President, Strategy and Chief Operating ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.